Class 22008The evolution of a patent infringement dispute

Class 22008The evolution of a patent infringement dispute -...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
The evolution of a patent infringement dispute Merck KGaA V. Integra Life Sciences Ms. Cathryn Campbell April 7 20008 No product case. Non-profit. Up and down among supreme court and lower courts. Basic: Receptor and side. Cell stick together when it should, or it is cancer. Protein three stick together xx- RGD-XXX which stick to cell to receptor Patent is filed on receptor. A substantially pure petide including as the cell attachedment promoting constituent. The amino acid sequence Arg-gly-asp-R wherein R is Ser, Cys Plaintiff The burnham institute: patent owner Telio pharmaceuticals: bankrupt original licensee Integra LifeSciences: exclusive Licensee The dendants March K sponsored infringing research and importd RGD petides Scripps : performed infringing research Dr. Chersh: performed infringing research Telio wants to license to Merk, but merk refused. Other company also reluctant to buy license. Then Telio sue.
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 08/27/2008 for the course LAW P E589 taught by Professor O'conor during the Spring '08 term at University of Washington.

Page1 / 3

Class 22008The evolution of a patent infringement dispute -...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online